| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 7.09e-05 | 11 | 154 | 3 | GO:0098973 | |
| GeneOntologyCellularComponent | PRC1 complex | 9.57e-06 | 19 | 152 | 4 | GO:0035102 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | CUL4B UBR1 POTEF POLR2A PRAMEF20 CCT4 PSMD10 PHC1 PHC2 RPP25 CUL5 BMI1 POTEE PHC3 BLOC1S6 MTOR DROSHA POTEI PRKAG2 | 8.40e-05 | 972 | 152 | 19 | GO:0140535 |
| Domain | Znf_FCS | 5.33e-06 | 5 | 153 | 3 | IPR012313 | |
| Domain | ZF_FCS | 1.06e-05 | 6 | 153 | 3 | PS51024 | |
| Domain | Actin/actin-like_CS | 1.21e-05 | 18 | 153 | 4 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 1.52e-05 | 19 | 153 | 4 | PS01132 | |
| Domain | ER_stress-assoc | 6.67e-05 | 2 | 153 | 2 | IPR010580 | |
| Domain | RAMP4 | 6.67e-05 | 2 | 153 | 2 | PF06624 | |
| Domain | ARM-type_fold | DOCK3 USP24 MROH5 ARFGEF2 LYST RYR3 FOCAD THADA UPF2 MTOR SYMPK | 1.13e-04 | 339 | 153 | 11 | IPR016024 |
| Domain | Actin | 1.15e-04 | 31 | 153 | 4 | IPR004000 | |
| Domain | Actin | 1.15e-04 | 31 | 153 | 4 | PF00022 | |
| Domain | ACTIN | 1.15e-04 | 31 | 153 | 4 | SM00268 | |
| Domain | Actin_CS | 2.79e-04 | 16 | 153 | 3 | IPR004001 | |
| Domain | ACTINS_2 | 3.37e-04 | 17 | 153 | 3 | PS00432 | |
| Domain | WHTH_DNA-bd_dom | 8.73e-04 | 242 | 153 | 8 | IPR011991 | |
| Domain | RIH_assoc-dom | 9.79e-04 | 6 | 153 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 9.79e-04 | 6 | 153 | 2 | PF08709 | |
| Domain | RIH_assoc | 9.79e-04 | 6 | 153 | 2 | PF08454 | |
| Domain | RIH_dom | 9.79e-04 | 6 | 153 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 9.79e-04 | 6 | 153 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 9.79e-04 | 6 | 153 | 2 | IPR015925 | |
| Domain | - | 9.79e-04 | 6 | 153 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 9.79e-04 | 6 | 153 | 2 | PF01365 | |
| Domain | SAM_DOMAIN | 1.11e-03 | 95 | 153 | 5 | PS50105 | |
| Domain | SAM | 1.22e-03 | 97 | 153 | 5 | IPR001660 | |
| Domain | Cullin_CS | 1.36e-03 | 7 | 153 | 2 | IPR016157 | |
| Domain | CULLIN | 1.36e-03 | 7 | 153 | 2 | SM00182 | |
| Domain | Cullin_neddylation_domain | 1.81e-03 | 8 | 153 | 2 | IPR019559 | |
| Domain | DHC_N1 | 1.81e-03 | 8 | 153 | 2 | PF08385 | |
| Domain | Cullin_Nedd8 | 1.81e-03 | 8 | 153 | 2 | PF10557 | |
| Domain | Cullin_Nedd8 | 1.81e-03 | 8 | 153 | 2 | SM00884 | |
| Domain | Dynein_heavy_dom-1 | 1.81e-03 | 8 | 153 | 2 | IPR013594 | |
| Domain | Ank_2 | 2.00e-03 | 215 | 153 | 7 | PF12796 | |
| Domain | - | 2.16e-03 | 218 | 153 | 7 | 1.10.10.10 | |
| Domain | Cullin_homology | 2.31e-03 | 9 | 153 | 2 | IPR016158 | |
| Domain | SAM_1 | 2.35e-03 | 68 | 153 | 4 | PF00536 | |
| Domain | Ank | 2.77e-03 | 228 | 153 | 7 | PF00023 | |
| Domain | SAM/pointed | 2.77e-03 | 117 | 153 | 5 | IPR013761 | |
| Domain | MIR | 2.87e-03 | 10 | 153 | 2 | PF02815 | |
| Domain | MIR_motif | 2.87e-03 | 10 | 153 | 2 | IPR016093 | |
| Domain | Cullin | 2.87e-03 | 10 | 153 | 2 | PF00888 | |
| Domain | MIR | 2.87e-03 | 10 | 153 | 2 | PS50919 | |
| Domain | MIR | 2.87e-03 | 10 | 153 | 2 | SM00472 | |
| Domain | CULLIN_2 | 2.87e-03 | 10 | 153 | 2 | PS50069 | |
| Domain | Cullin_N | 2.87e-03 | 10 | 153 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 2.87e-03 | 10 | 153 | 2 | PS01256 | |
| Domain | CENP-B_N | 2.87e-03 | 10 | 153 | 2 | PF04218 | |
| Domain | Cullin_repeat-like_dom | 4.17e-03 | 12 | 153 | 2 | IPR016159 | |
| Domain | HTH_Psq | 4.17e-03 | 12 | 153 | 2 | IPR007889 | |
| Domain | HTH_PSQ | 4.17e-03 | 12 | 153 | 2 | PS50960 | |
| Domain | CENPB | 4.17e-03 | 12 | 153 | 2 | SM00674 | |
| Domain | DDE_1 | 4.17e-03 | 12 | 153 | 2 | PF03184 | |
| Domain | DDE_SF_endonuclease_dom | 4.17e-03 | 12 | 153 | 2 | IPR004875 | |
| Domain | - | 4.40e-03 | 248 | 153 | 7 | 1.25.40.20 | |
| Domain | ANK | 4.69e-03 | 251 | 153 | 7 | SM00248 | |
| Domain | ANK_REPEAT | 4.90e-03 | 253 | 153 | 7 | PS50088 | |
| Domain | HTH_CENPB | 4.90e-03 | 13 | 153 | 2 | PS51253 | |
| Domain | HTH_Tnp_Tc5 | 4.90e-03 | 13 | 153 | 2 | PF03221 | |
| Domain | HTH_CenpB_DNA-bd_dom | 4.90e-03 | 13 | 153 | 2 | IPR006600 | |
| Domain | Ankyrin_rpt-contain_dom | 5.00e-03 | 254 | 153 | 7 | IPR020683 | |
| Domain | ANK_REP_REGION | 5.00e-03 | 254 | 153 | 7 | PS50297 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.69e-03 | 14 | 153 | 2 | IPR024317 | |
| Domain | VitD_rcpt | 5.69e-03 | 14 | 153 | 2 | IPR000324 | |
| Domain | Dynein_HC_stalk | 5.69e-03 | 14 | 153 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.69e-03 | 14 | 153 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.69e-03 | 14 | 153 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 5.69e-03 | 14 | 153 | 2 | IPR011704 | |
| Domain | MT | 5.69e-03 | 14 | 153 | 2 | PF12777 | |
| Domain | AAA_8 | 5.69e-03 | 14 | 153 | 2 | PF12780 | |
| Domain | AAA_5 | 5.69e-03 | 14 | 153 | 2 | PF07728 | |
| Domain | Ankyrin_rpt | 5.91e-03 | 262 | 153 | 7 | IPR002110 | |
| Domain | SAM | 5.93e-03 | 88 | 153 | 4 | SM00454 | |
| Domain | DHC_fam | 6.53e-03 | 15 | 153 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 6.53e-03 | 15 | 153 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.53e-03 | 15 | 153 | 2 | IPR004273 | |
| Domain | AAA | 6.68e-03 | 144 | 153 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 6.68e-03 | 144 | 153 | 5 | IPR003593 | |
| Domain | CBS | 7.42e-03 | 16 | 153 | 2 | SM00116 | |
| Domain | PINT | 7.42e-03 | 16 | 153 | 2 | SM00088 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 2.25e-06 | 26 | 119 | 5 | M47923 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS | 8.12e-06 | 16 | 119 | 4 | M27403 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 1.21e-05 | 61 | 119 | 6 | M27811 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CUL4B UBR1 RBM15 GCFC2 SFSWAP POLR2A USP24 ARFGEF2 RFC1 CLIP1 GATAD2B PHC2 BLM PHC3 GSE1 MAD1L1 TIMELESS SYMPK | 1.42e-08 | 774 | 156 | 18 | 15302935 |
| Pubmed | CUL4B DCDC1 SFSWAP CENPB POLR2A VPS50 TSPYL2 SRP9 TRIM24 GATAD2B DAP3 FOXP4 THADA GSE1 DROSHA ANKRD2 GNL2 CLSPN GARRE1 ANKS3 WWC1 | 3.19e-08 | 1116 | 156 | 21 | 31753913 | |
| Pubmed | 8.85e-08 | 3 | 156 | 3 | 9121482 | ||
| Pubmed | STARD13 VIL1 MYH8 POTEF KIF21A GPS1 SRP9 CCT4 CAGE1 SERP2 SERP1 STK31 LYST MIPOL1 POTEE DAP3 CLCN4 DNAJA4 EIF3A POTEI CADPS2 TUBD1 DNAH8 | 1.33e-07 | 1442 | 156 | 23 | 35575683 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CUL4B PDE4D PUF60 KIF21A POLR2A GPS1 RPS10 USP24 ARFGEF2 SRP9 CCT4 PSMD10 RUFY1 CLIP1 RPP25 CUL5 MTOR MAD1L1 TIMELESS EIF3A FH SNRPD1 COPS5 | 1.56e-07 | 1455 | 156 | 23 | 22863883 |
| Pubmed | Several distinct polycomb complexes regulate and co-localize on the INK4a tumor suppressor locus. | 1.87e-07 | 12 | 156 | 4 | 19636380 | |
| Pubmed | GPS1 VPS50 USP24 SRP9 PSMD10 RFC1 BHMT ITPR3 CUL5 SMYD4 DROSHA EIF3A COPS5 | 2.99e-07 | 481 | 156 | 13 | 28190767 | |
| Pubmed | mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. | 3.53e-07 | 4 | 156 | 3 | 11296225 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RBM15 DMXL2 DDX49 SFSWAP RRP1B PUF60 POLR2A BCKDK RPS10 SRP9 PHC2 BLM DAP3 UPF2 ZNF532 DROSHA GNL2 SNRPD1 SYMPK | 4.36e-07 | 1082 | 156 | 19 | 38697112 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | CUL4B POLR2A GATAD2B CUL5 GSE1 UPF2 MAD1L1 GNL2 TRMT1L SNRPD1 SYMPK | 4.50e-07 | 341 | 156 | 11 | 32971831 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 4.51e-07 | 271 | 156 | 10 | 32433965 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | RBM15 IFT74 VPS50 RTN3 RUFY1 BLM POTEE BRF1 GSE1 DROSHA CENPH POTEI CLSPN GARRE1 | 4.72e-07 | 588 | 156 | 14 | 38580884 |
| Pubmed | RBM15 PDE4D RRP1B GPS1 USP24 RFC1 TRIM29 CLIP1 GATAD2B BLM MAD1L1 TIMELESS ANKS3 | 4.94e-07 | 503 | 156 | 13 | 16964243 | |
| Pubmed | CUL4B GCFC2 SFSWAP ATG2B ARFGEF2 GATAD2B MTOR RPS10P5 TRMT1L | 6.06e-07 | 215 | 156 | 9 | 35973513 | |
| Pubmed | CUL4B PUF60 IFT74 POLR2A GPS1 RPS10 CCT4 C1orf167 RFC1 GATAD2B CUL5 DAP3 CEP78 PTCD1 MRPS21 EIF3A RPS10P5 TRMT1L SNRPD1 COPS5 HSPA14 | 6.18e-07 | 1335 | 156 | 21 | 29229926 | |
| Pubmed | 6.80e-07 | 16 | 156 | 4 | 12167701 | ||
| Pubmed | CUL4B RBM15 CENPB PUF60 POLR2A CCT4 MAU2 RFC1 GATAD2B PHC2 BLM CUL5 ZNF532 CENPH MAD1L1 EIF3A TRMT1L SYMPK | 7.69e-07 | 1014 | 156 | 18 | 32416067 | |
| Pubmed | RBM15 SFSWAP RRP1B PUF60 RPS10 SRP9 RFC1 DAP3 CEP78 UPF2 MRPS21 GNL2 TRMT1L SNRPD1 SYMPK | 8.57e-07 | 713 | 156 | 15 | 29802200 | |
| Pubmed | RING1 is associated with the polycomb group protein complex and acts as a transcriptional repressor. | 8.79e-07 | 5 | 156 | 3 | 9199346 | |
| Pubmed | LEMD3 PUF60 POTEF GPS1 RPS10 SRP9 CCT4 PSMD10 RFC1 UPF2 MTOR EIF3A FH | 1.05e-06 | 538 | 156 | 13 | 28524877 | |
| Pubmed | 1.27e-06 | 42 | 156 | 5 | 34581821 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CUL4B NR2C1 RBM15 SFSWAP RRP1B LEMD3 PUF60 POLR2A RPS10 RFC1 TRIM24 GATAD2B BLM PHC3 GNL2 RPS10P5 SYMPK | 1.51e-06 | 954 | 156 | 17 | 36373674 |
| Pubmed | CUL4B RBM15 RRP1B PUF60 POLR2A RPS10 USP24 RFC1 ITPR3 BLM MTOR GNL2 FH SYMPK | 1.62e-06 | 653 | 156 | 14 | 22586326 | |
| Pubmed | NR2C1 RRP1B RPS10 CCT4 RFC1 MBD6 TRIM24 GATAD2B BLM FHAD1 DAP3 PHC3 FOXP4 TIMM10 GSE1 MRPS21 GNL2 EIF3A TRMT1L GARRE1 SYMPK | 1.82e-06 | 1429 | 156 | 21 | 35140242 | |
| Pubmed | CENPB RRP1B BCKDK SRP9 CCT4 RFC1 JMY ITPR3 CUL5 ZBP1 DAP3 THADA MTOR VPS35L MRPS21 GNL2 EIF3A CTNNA2 TRMT1L SNRPD1 GARRE1 | 2.06e-06 | 1440 | 156 | 21 | 30833792 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CUL4B STARD13 CENPB RRP1B IFT74 GPS1 VPS50 ATG2B CLIP1 MIPOL1 BLM THADA TIMM10 MTOR CENPH PIBF1 SNRPD1 COPS5 ANKS3 CCDC144A | 2.10e-06 | 1321 | 156 | 20 | 27173435 |
| Pubmed | SENP3 and USP7 regulate Polycomb-rixosome interactions and silencing functions. | 2.20e-06 | 21 | 156 | 4 | 37014752 | |
| Pubmed | PRC1 and Suv39h specify parental asymmetry at constitutive heterochromatin in early mouse embryos. | 2.20e-06 | 21 | 156 | 4 | 18311137 | |
| Pubmed | 2.21e-06 | 187 | 156 | 8 | 26460568 | ||
| Pubmed | 3.06e-06 | 7 | 156 | 3 | 15563468 | ||
| Pubmed | 3.38e-06 | 339 | 156 | 10 | 30415952 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CUL4B PDE4D DDX49 LEMD3 POLR2A GPS1 MAU2 TRIM29 CLIP1 BLM CEP78 DNAJA4 MAD1L1 TIMELESS EIF3A PIBF1 SNRPD1 COPS5 | 4.76e-06 | 1155 | 156 | 18 | 20360068 |
| Pubmed | 4.80e-06 | 147 | 156 | 7 | 29576527 | ||
| Pubmed | MAPKAP kinase MK2 maintains self-renewal capacity of haematopoietic stem cells. | 4.88e-06 | 8 | 156 | 3 | 19369945 | |
| Pubmed | Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. | 4.88e-06 | 8 | 156 | 3 | 22542159 | |
| Pubmed | RBM15 DDX49 SFSWAP PUF60 POLR2A FASTKD1 CCT4 PHC1 BMI1 PTCD1 MRPS21 GNL2 TRMT1L SNRPD1 | 5.23e-06 | 723 | 156 | 14 | 34133714 | |
| Pubmed | AKAP6 DOCK3 NR2C1 DMXL2 DSCAM IFT74 KIF21A TSPYL2 ARFGEF2 RYR3 MIPOL1 FOCAD ZNF532 DROSHA ASPA VPS35L PKD1 CADPS2 COPS5 | 5.40e-06 | 1285 | 156 | 19 | 35914814 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | DOCK3 RBM15 RRP1B ABCA13 STK31 MIPOL1 GSE1 EIF3A CADPS2 DNAH9 | 5.88e-06 | 361 | 156 | 10 | 26167880 |
| Pubmed | AMBRA1 interplay with cullin E3 ubiquitin ligases regulates autophagy dynamics. | 6.44e-06 | 58 | 156 | 5 | 25499913 | |
| Pubmed | RBM15 SFSWAP RRP1B PUF60 RPS10 TSPYL2 SRP9 CCT4 RFC1 DROSHA GNL2 EIF3A TRMT1L SNRPD1 SYMPK | 6.95e-06 | 847 | 156 | 15 | 35850772 | |
| Pubmed | RBM15 DDX49 LEMD3 IFT74 POLR2A RPS10 ATG2B PSMD10 RFC1 PHC1 PHC2 DYRK1B PIBF1 | 7.52e-06 | 645 | 156 | 13 | 25281560 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | CENPB PUF60 IFT74 POLR2A TRIM29 TRIM24 CREB5 GATAD2B BLM FOXP4 GSE1 MAD1L1 TRMT1L HSPA14 SYMPK | 7.99e-06 | 857 | 156 | 15 | 25609649 |
| Pubmed | RBM15 RRP1B RPS10 SRP9 CCT4 RFC1 DAP3 UPF2 DNAJA4 MRPS21 GNL2 EIF3A CTNNA2 TRMT1L CLSPN NCKAP1L | 8.35e-06 | 971 | 156 | 16 | 33306668 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 PDE4A PUF60 POLR2A ARFGEF2 MBD6 LYST PHC2 ITPR3 FOCAD THADA MTOR MAD1L1 PKD1 TIGD3 DIP2C SYMPK | 1.05e-05 | 1105 | 156 | 17 | 35748872 |
| Pubmed | A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy. | 1.13e-05 | 65 | 156 | 5 | 27453043 | |
| Pubmed | DDX49 SFSWAP RRP1B LEMD3 POLR2A BCKDK SRP9 CCT4 GATAD2B PHC2 BLM POTEE PHC3 PTCD1 DROSHA CRACDL GNL2 EIF3A CTNNA2 TRMT1L | 1.33e-05 | 1497 | 156 | 20 | 31527615 | |
| Pubmed | VIL1 RBM15 SFSWAP RRP1B PUF60 BCKDK SRP9 RFC1 CLIP1 PHC2 PHC3 GPC3 CEP78 UPF2 DROSHA GNL2 CTNNA2 SNRPD1 HSPA14 | 1.34e-05 | 1371 | 156 | 19 | 36244648 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RBM15 PUF60 KIF21A USP24 ARFGEF2 CCT4 BLM MAD1L1 TRMT1L SNRPD1 COPS5 SYMPK | 1.36e-05 | 582 | 156 | 12 | 20467437 |
| Pubmed | 1.42e-05 | 11 | 156 | 3 | 12183370 | ||
| Pubmed | PDE4A RRP1B PUF60 POTEF RPS10 SRP9 CCT4 GATAD2B RPP25 POTEE DAP3 MRPS21 EIF3A RPS10P5 TRMT1L POTEI SNRPD1 | 1.81e-05 | 1153 | 156 | 17 | 29845934 | |
| Pubmed | 1.89e-05 | 12 | 156 | 3 | 20399188 | ||
| Pubmed | Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair? | 2.00e-05 | 2 | 156 | 2 | 17102641 | |
| Pubmed | A complex RARE is required for the majority of Nedd9 embryonic expression. | 2.00e-05 | 2 | 156 | 2 | 25120220 | |
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 2.00e-05 | 2 | 156 | 2 | 19669888 | |
| Pubmed | BMI1 regulates PRC1 architecture and activity through homo- and hetero-oligomerization. | 2.00e-05 | 2 | 156 | 2 | 27827373 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 26191215 | ||
| Pubmed | The FKBP12-rapamycin-associated protein (FRAP) is a CLIP-170 kinase. | 2.00e-05 | 2 | 156 | 2 | 12231510 | |
| Pubmed | Lymphoblastic lymphoma in a colony of N:NIH(S)-bg-nu-xid mice. | 2.00e-05 | 2 | 156 | 2 | 1434498 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 3902123 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 9520403 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 30971527 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 25139996 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 12384788 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 27280401 | ||
| Pubmed | Altered expression of COP9 signalosome proteins in preeclampsia. | 2.00e-05 | 2 | 156 | 2 | 22103747 | |
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 24320561 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 30796221 | ||
| Pubmed | 2.00e-05 | 2 | 156 | 2 | 24970801 | ||
| Pubmed | 2.08e-05 | 418 | 156 | 10 | 34709266 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | NR2C1 RRP1B RFC1 TRIM24 GATAD2B PHC1 BLM BMI1 DAP3 PHC3 GNL2 TIMELESS | 2.10e-05 | 608 | 156 | 12 | 36089195 |
| Pubmed | 2.45e-05 | 13 | 156 | 3 | 16861906 | ||
| Pubmed | 2.45e-05 | 13 | 156 | 3 | 11950896 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | LEMD3 FASTKD1 PAQR5 ARFGEF2 ECI1 CLIP1 BLM FOCAD THADA VPS41 TIMELESS CTNNA2 FH GFM1 GARRE1 SYMPK | 2.47e-05 | 1061 | 156 | 16 | 33845483 |
| Pubmed | CUL4B NR2C1 MIA3 GCFC2 LEMD3 POLR2A VPS50 SRP9 GATAD2B GNL2 DCLRE1A CLSPN GFM1 | 2.87e-05 | 733 | 156 | 13 | 34672954 | |
| Pubmed | 3.11e-05 | 14 | 156 | 3 | 22474075 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | RRP1B POLR2A MAU2 RFC1 JMY GATAD2B PHC1 PHC2 BMI1 PHC3 CEP78 | 3.12e-05 | 533 | 156 | 11 | 30554943 |
| Pubmed | PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. | 3.47e-05 | 41 | 156 | 4 | 22325352 | |
| Pubmed | Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor. | 3.87e-05 | 15 | 156 | 3 | 20601937 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 3.87e-05 | 15 | 156 | 3 | 16824795 | |
| Pubmed | UBR1 DMXL2 MIA3 CUL5 SMYD4 GSE1 CEP78 UPF2 DROSHA TIMELESS CLSPN GARRE1 | 4.01e-05 | 650 | 156 | 12 | 38777146 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RBM15 CENPB RRP1B BCKDK RFC1 BLM CEP78 UPF2 DROSHA CENPH GNL2 TRMT1L HSPA14 | 4.11e-05 | 759 | 156 | 13 | 35915203 |
| Pubmed | RBM15 CENPB ABCA13 POLR2A RPS10 TRIM29 GATAD2B ITPR3 BLM POTEE DCLRE1A SNRPD1 | 4.13e-05 | 652 | 156 | 12 | 31180492 | |
| Pubmed | Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome. | 4.19e-05 | 43 | 156 | 4 | 34672947 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RBM15 SFSWAP RRP1B POLR2A RPS10 SRP9 CCT4 RFC1 PHC2 BLM GNL2 EIF3A CLSPN GFM1 SYMPK | 4.20e-05 | 989 | 156 | 15 | 36424410 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MIA3 RRP1B LEMD3 BCKDK FASTKD1 ATG2B RTN3 CCT4 ITPR3 BLM POTEE DAP3 THADA UPF2 MRPS21 GNL2 APOL2 GFM1 MTRF1L | 4.41e-05 | 1496 | 156 | 19 | 32877691 |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | GCFC2 CENPB ESR2 POLR2A NFKBIZ RFC1 TRIM29 TRIM24 BMI1 BRF1 ANKRD2 DIP2C TIMELESS ANKS3 | 4.42e-05 | 877 | 156 | 14 | 20211142 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | FNIP2 STARD13 DMXL2 PRAMEF20 USP24 MAU2 TRIM29 SMYD4 MTOR CRACDL MRPS21 TIMELESS APOL2 GFM1 VWA5B1 MTRF1L SYMPK | 4.59e-05 | 1242 | 156 | 17 | 30973865 |
| Pubmed | 4.69e-05 | 285 | 156 | 8 | 32838362 | ||
| Pubmed | 4.75e-05 | 16 | 156 | 3 | 16036220 | ||
| Pubmed | 4.75e-05 | 16 | 156 | 3 | 24126761 | ||
| Pubmed | 4.75e-05 | 16 | 156 | 3 | 15386022 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 4.79e-05 | 370 | 156 | 9 | 22922362 | |
| Pubmed | 4.82e-05 | 210 | 156 | 7 | 16565220 | ||
| Pubmed | CUL4B IFT74 GPS1 VPS50 RFC1 GATAD2B DAP3 TIMELESS GFM1 COPS5 SYMPK | 4.87e-05 | 560 | 156 | 11 | 35241646 | |
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 5.22e-05 | 89 | 156 | 5 | 22446626 | |
| Pubmed | RRP1B PUF60 GPS1 RPS10 CCT4 GATAD2B DAP3 EIF3A TRMT1L SNRPD1 | 5.49e-05 | 469 | 156 | 10 | 37314180 | |
| Pubmed | 5.98e-05 | 47 | 156 | 4 | 15009096 | ||
| Pubmed | 5.98e-05 | 3 | 156 | 2 | 31251475 | ||
| Pubmed | 5.98e-05 | 3 | 156 | 2 | 20106966 | ||
| Pubmed | 5.98e-05 | 3 | 156 | 2 | 16912167 | ||
| Interaction | HSP90AA2P interactions | 3.84e-06 | 55 | 154 | 6 | int:HSP90AA2P | |
| Interaction | ABT1 interactions | DDX49 CENPB RRP1B RPS10 TSPYL2 RPP25 BLM DAP3 PTCD1 DROSHA MRPS21 GNL2 TRMT1L ANKS3 | 4.75e-06 | 423 | 154 | 14 | int:ABT1 |
| Interaction | SRP14 interactions | RBM15 RRP1B ESR2 SRP9 BLM BMI1 DAP3 DNAJA4 MRPS21 GNL2 CLSPN SNRPD1 COPS5 | 4.93e-06 | 366 | 154 | 13 | int:SRP14 |
| Interaction | ERCC8 interactions | 5.04e-06 | 124 | 154 | 8 | int:ERCC8 | |
| Interaction | SNRNP40 interactions | CUL4B NR2C1 RBM15 GCFC2 SFSWAP RRP1B GPS1 RFC1 TRIM24 BLM PHC3 GSE1 ZNF532 GNL2 TRMT1L SNRPD1 COPS5 | 7.87e-06 | 637 | 154 | 17 | int:SNRNP40 |
| Interaction | SRPK2 interactions | DOCK3 RBM15 SFSWAP RRP1B PUF60 ESR2 POLR2A GPS1 RPS10 MIPOL1 BMI1 GSE1 DROSHA GNL2 EIF3A CADPS2 SNRPD1 DNAH9 | 9.65e-06 | 717 | 154 | 18 | int:SRPK2 |
| Interaction | NPTN interactions | DMXL2 GCFC2 VPS50 FASTKD1 USP24 ARFGEF2 FOCAD THADA MTOR APOL2 SYMPK | 9.93e-06 | 278 | 154 | 11 | int:NPTN |
| Interaction | ASB6 interactions | 1.10e-05 | 99 | 154 | 7 | int:ASB6 | |
| Interaction | ADAR interactions | PUF60 POTEF ESR2 SRP9 MAU2 BMI1 POTEE DROSHA GNL2 TRMT1L POTEI | 1.30e-05 | 286 | 154 | 11 | int:ADAR |
| Interaction | DDB2 interactions | 1.44e-05 | 143 | 154 | 8 | int:DDB2 | |
| Interaction | RPS26P54 interactions | 1.50e-05 | 7 | 154 | 3 | int:RPS26P54 | |
| Interaction | AKR7L interactions | 1.86e-05 | 72 | 154 | 6 | int:AKR7L | |
| Interaction | SNRNP70 interactions | CUL4B RBM15 SFSWAP RRP1B PUF60 PLEKHG7 ESR2 POLR2A RPS10 SRP9 RFC1 CUL5 DAP3 CEP78 UPF2 MRPS21 GNL2 TRMT1L SNRPD1 COPS5 SYMPK | 1.98e-05 | 984 | 154 | 21 | int:SNRNP70 |
| Interaction | COPS9 interactions | 2.33e-05 | 45 | 154 | 5 | int:COPS9 | |
| Interaction | RPL21P19 interactions | 2.38e-05 | 8 | 154 | 3 | int:RPL21P19 | |
| Interaction | RPL21P16 interactions | 2.38e-05 | 8 | 154 | 3 | int:RPL21P16 | |
| Interaction | NUP43 interactions | NR2C1 RBM15 DSCAM RRP1B IFT74 TSPYL2 SRP9 RFC1 BLM PHC3 GSE1 ZNF532 GNL2 TIMELESS TRMT1L DNAH9 | 2.46e-05 | 625 | 154 | 16 | int:NUP43 |
| Interaction | CBX7 interactions | 2.60e-05 | 46 | 154 | 5 | int:CBX7 | |
| Interaction | RPL29P30 interactions | 3.55e-05 | 9 | 154 | 3 | int:RPL29P30 | |
| Interaction | RBM3 interactions | 3.70e-05 | 163 | 154 | 8 | int:RBM3 | |
| Interaction | RPS16 interactions | CUL4B RRP1B RPS10 TSPYL2 SRP9 RFC1 MBD6 TRIM24 RUFY1 BLM CUL5 FOCAD GNL2 EIF3A RPS10P5 TRMT1L COPS5 | 4.03e-05 | 724 | 154 | 17 | int:RPS16 |
| Interaction | RBM42 interactions | SFSWAP RRP1B ESR2 RPS10 PTCD1 MRPS21 GNL2 EIF3A TRMT1L SNRPD1 COPS5 | 4.95e-05 | 331 | 154 | 11 | int:RBM42 |
| Interaction | RPL7AP9 interactions | 5.05e-05 | 10 | 154 | 3 | int:RPL7AP9 | |
| Interaction | GYPA interactions | 5.88e-05 | 174 | 154 | 8 | int:GYPA | |
| Interaction | RPL23A interactions | CUL4B RRP1B RPS10 SRP9 RUFY1 CLIP1 MIPOL1 BLM CUL5 MTOR GNL2 RPS10P5 TRMT1L GFM1 COPS5 | 6.52e-05 | 606 | 154 | 15 | int:RPL23A |
| Interaction | PCGF3 interactions | 6.63e-05 | 90 | 154 | 6 | int:PCGF3 | |
| Interaction | RPL7P32 interactions | 6.90e-05 | 11 | 154 | 3 | int:RPL7P32 | |
| Interaction | RPSAP12 interactions | 6.90e-05 | 11 | 154 | 3 | int:RPSAP12 | |
| Interaction | H2AC17 interactions | 7.58e-05 | 232 | 154 | 9 | int:H2AC17 | |
| Interaction | ITPKB interactions | 7.70e-05 | 30 | 154 | 4 | int:ITPKB | |
| Interaction | MAPKAPK2 interactions | 7.74e-05 | 134 | 154 | 7 | int:MAPKAPK2 | |
| Interaction | KLF15 interactions | 8.09e-05 | 290 | 154 | 10 | int:KLF15 | |
| Interaction | LHX2 interactions | 8.38e-05 | 183 | 154 | 8 | int:LHX2 | |
| Interaction | GFI1B interactions | 8.50e-05 | 136 | 154 | 7 | int:GFI1B | |
| Interaction | SSB interactions | CUL4B PUF60 ESR2 RPS10 SRP9 CCT4 TRIM24 BMI1 MTOR TIMELESS EIF3A SNRPD1 COPS5 | 9.09e-05 | 484 | 154 | 13 | int:SSB |
| Interaction | RPL36AP37 interactions | 9.15e-05 | 12 | 154 | 3 | int:RPL36AP37 | |
| Interaction | CSNK2B interactions | DSCAM CENPB RRP1B ESR2 POLR2A TSPYL2 ARFGEF2 RFC1 LYST GATAD2B PHC2 ITPR3 BLM BMI1 CLSPN | 9.20e-05 | 625 | 154 | 15 | int:CSNK2B |
| Interaction | ADARB1 interactions | RRP1B PUF60 POTEF RPS10 RFC1 BLM BMI1 DAP3 GNL2 EIF3A TRMT1L POTEI SNRPD1 | 1.01e-04 | 489 | 154 | 13 | int:ADARB1 |
| Interaction | EPB41L2 interactions | 1.04e-04 | 299 | 154 | 10 | int:EPB41L2 | |
| Interaction | SOX15 interactions | 1.07e-04 | 141 | 154 | 7 | int:SOX15 | |
| Interaction | KLHL4 interactions | 1.13e-04 | 33 | 154 | 4 | int:KLHL4 | |
| Interaction | CHEK1 interactions | 1.15e-04 | 245 | 154 | 9 | int:CHEK1 | |
| Interaction | RPL7AP27 interactions | 1.18e-04 | 13 | 154 | 3 | int:RPL7AP27 | |
| Interaction | HNRNPU interactions | RRP1B LEMD3 POLR2A RPS10 SRP9 MAU2 RFC1 TRIM29 TRIM24 CUL5 FOCAD DAP3 BRF1 PTCD1 MRPS21 GNL2 EIF3A TRMT1L SNRPD1 COPS5 | 1.24e-04 | 1035 | 154 | 20 | int:HNRNPU |
| Interaction | CSNK2A2 interactions | CUL4B GCFC2 RRP1B RPS10 TSPYL2 CCT4 LYST GATAD2B PHC1 PHC2 BMI1 PHC3 BRF1 EIF3A TRMT1L ANKS3 | 1.26e-04 | 718 | 154 | 16 | int:CSNK2A2 |
| Interaction | NCL interactions | CUL4B RRP1B PUF60 ESR2 POLR2A RPS10 SRP9 MAU2 RFC1 RUFY1 CUL5 BMI1 DAP3 BRF1 EIF3A SNRPD1 COPS5 | 1.32e-04 | 798 | 154 | 17 | int:NCL |
| Interaction | MAPKAP1 interactions | 1.33e-04 | 146 | 154 | 7 | int:MAPKAP1 | |
| Interaction | KHSRP interactions | 1.33e-04 | 308 | 154 | 10 | int:KHSRP | |
| Interaction | MRPS31 interactions | 1.40e-04 | 310 | 154 | 10 | int:MRPS31 | |
| Interaction | GAN interactions | 1.46e-04 | 253 | 154 | 9 | int:GAN | |
| Interaction | PCBD1 interactions | 1.48e-04 | 104 | 154 | 6 | int:PCBD1 | |
| Interaction | CENPA interactions | DDX49 CENPB RRP1B LEMD3 RFC1 GATAD2B PHC2 BLM BMI1 CENPH GNL2 | 1.57e-04 | 377 | 154 | 11 | int:CENPA |
| Interaction | POU5F1 interactions | CUL4B LEMD3 SRP9 CCT4 PSMD10 RFC1 TRIM24 CLIP1 GATAD2B PHC1 ITPR3 FOXP4 PLD2 SYMPK | 1.61e-04 | 584 | 154 | 14 | int:POU5F1 |
| Interaction | TRIM27 interactions | CUL4B MIA3 ESR2 TRIM29 CREB5 GATAD2B CUL5 NEDD9 BMI1 BRF1 GSE1 PIBF1 GARRE1 | 1.65e-04 | 514 | 154 | 13 | int:TRIM27 |
| Interaction | RECQL4 interactions | CUL4B UBR1 PUF60 IFT74 PLEKHG7 POLR2A GPS1 RPS10 CCT4 C1orf167 RFC1 GATAD2B CUL5 DAP3 CEP78 PTCD1 MRPS21 TIMELESS EIF3A RPS10P5 TRMT1L SNRPD1 COPS5 HSPA14 | 1.81e-04 | 1412 | 154 | 24 | int:RECQL4 |
| Interaction | SIRT7 interactions | CUL4B RBM15 RRP1B PUF60 ESR2 POLR2A RPS10 USP24 RFC1 ITPR3 BLM MTOR GNL2 FH COPS5 SYMPK | 1.89e-04 | 744 | 154 | 16 | int:SIRT7 |
| Interaction | BRCA1 interactions | CUL4B UBR1 CENPB ESR2 POLR2A ARFGEF2 CCT4 MAU2 RFC1 TRIM29 TRIM24 RUFY1 CLIP1 CREB5 GATAD2B BLM DNAJA4 MTOR DCLRE1A EIF3A CLSPN HSPA14 | 2.11e-04 | 1249 | 154 | 22 | int:BRCA1 |
| Interaction | H2AC16 interactions | 2.28e-04 | 16 | 154 | 3 | int:H2AC16 | |
| Interaction | H2AC15 interactions | 2.28e-04 | 16 | 154 | 3 | int:H2AC15 | |
| Interaction | RICTOR interactions | CUL4B GCFC2 SFSWAP PLEKHG7 ESR2 ATG2B ARFGEF2 CCT4 GATAD2B CUL5 MTOR EIF3A RPS10P5 TRMT1L APOL2 NCKAP1L | 2.37e-04 | 759 | 154 | 16 | int:RICTOR |
| Interaction | EFTUD2 interactions | RRP1B PUF60 KIF21A POLR2A RPS10 USP24 SRP9 CCT4 RFC1 TRIM24 RUFY1 CUL5 BMI1 DAP3 BRF1 DNAJA4 MRPS21 GNL2 EIF3A TRMT1L SNRPD1 COPS5 HSPA14 SYMPK | 2.66e-04 | 1449 | 154 | 24 | int:EFTUD2 |
| Interaction | KLHL18 interactions | 2.66e-04 | 41 | 154 | 4 | int:KLHL18 | |
| Interaction | APEX1 interactions | NR2C1 GCFC2 DDX49 RRP1B PUF60 IFT74 ESR2 MAU2 RFC1 TRIM24 BLM THADA TIMM10 BRF1 GSE1 DROSHA MAD1L1 PKD1 GNL2 TUBD1 SNRPD1 WWC1 | 2.69e-04 | 1271 | 154 | 22 | int:APEX1 |
| Interaction | CIRBP interactions | 2.71e-04 | 164 | 154 | 7 | int:CIRBP | |
| Interaction | AKAP6 interactions | 2.75e-04 | 17 | 154 | 3 | int:AKAP6 | |
| Interaction | TOP1 interactions | CUL4B RBM15 RRP1B POLR2A MAU2 RFC1 TRIM24 GATAD2B MTOR EIF3A FH TUBD1 SNRPD1 COPS5 SYMPK | 2.95e-04 | 696 | 154 | 15 | int:TOP1 |
| Interaction | KDM1A interactions | NR2C1 IFT74 ESR2 POLR2A VPS50 ATG2B USP24 CAGE1 TRIM24 RUFY1 PHC1 PHC2 ZBP1 BMI1 PHC3 GSE1 ZNF532 SYMPK | 3.14e-04 | 941 | 154 | 18 | int:KDM1A |
| Interaction | INSYN1 interactions | 3.25e-04 | 169 | 154 | 7 | int:INSYN1 | |
| Interaction | TERF2IP interactions | NR2C1 SFSWAP PUF60 ESR2 RFC1 TRIM24 GATAD2B PHC1 RPP25 BLM PHC3 CLSPN SYMPK | 3.29e-04 | 552 | 154 | 13 | int:TERF2IP |
| Interaction | CBX6 interactions | 3.36e-04 | 283 | 154 | 9 | int:CBX6 | |
| Interaction | BCAR1 interactions | GCFC2 KIF21A POLR2A ATG2B TRIM29 PHC2 CUL5 NEDD9 MTOR CENPH PKD1 TRMT1L GARRE1 | 3.52e-04 | 556 | 154 | 13 | int:BCAR1 |
| Interaction | POC1A interactions | 3.52e-04 | 122 | 154 | 6 | int:POC1A | |
| Interaction | MLLT1 interactions | 3.68e-04 | 123 | 154 | 6 | int:MLLT1 | |
| Interaction | MRM1 interactions | 3.70e-04 | 350 | 154 | 10 | int:MRM1 | |
| Interaction | NLE1 interactions | 3.76e-04 | 228 | 154 | 8 | int:NLE1 | |
| Interaction | GLI4 interactions | 4.01e-04 | 125 | 154 | 6 | int:GLI4 | |
| Interaction | ZGPAT interactions | 4.16e-04 | 176 | 154 | 7 | int:ZGPAT | |
| Interaction | RYBP interactions | 4.22e-04 | 232 | 154 | 8 | int:RYBP | |
| Interaction | RPS3 interactions | CUL4B ESR2 RPS10 SRP9 MBD6 TRIM24 RUFY1 CUL5 BMI1 PHC3 BTK GNL2 EIF3A RPS10P5 COPS5 | 4.28e-04 | 721 | 154 | 15 | int:RPS3 |
| Interaction | H2AC8 interactions | 4.30e-04 | 177 | 154 | 7 | int:H2AC8 | |
| Interaction | H3C3 interactions | NR2C1 RRP1B RFC1 TRIM24 GATAD2B PHC1 BLM BMI1 DAP3 PHC3 GNL2 TIMELESS | 4.32e-04 | 495 | 154 | 12 | int:H3C3 |
| Interaction | PARP1 interactions | NR2C1 DDX49 CENPB RRP1B LEMD3 POLR2A RFC1 MBD6 TRIM29 GATAD2B PHC1 BLM BMI1 PHC3 BRF1 MTOR GNL2 TIMELESS TRMT1L CLSPN TUBD1 COPS5 | 4.34e-04 | 1316 | 154 | 22 | int:PARP1 |
| Interaction | ARL16 interactions | 4.39e-04 | 83 | 154 | 5 | int:ARL16 | |
| Interaction | SRP9 interactions | RRP1B POLR2A RPS10 SRP9 RFC1 BLM BMI1 GNL2 EIF3A CLSPN SNRPD1 | 4.54e-04 | 427 | 154 | 11 | int:SRP9 |
| Interaction | ACTBL2 interactions | 4.65e-04 | 296 | 154 | 9 | int:ACTBL2 | |
| Interaction | DOT1L interactions | RBM15 SFSWAP RRP1B PUF60 RPS10 TSPYL2 SRP9 CCT4 BRINP1 RFC1 DROSHA GNL2 EIF3A TRMT1L SNRPD1 SYMPK | 4.66e-04 | 807 | 154 | 16 | int:DOT1L |
| Interaction | WDR77 interactions | CUL4B ESR2 RPS10 CCT4 MAU2 RUFY1 GATAD2B TIMELESS RPS10P5 SNRPD1 | 4.71e-04 | 361 | 154 | 10 | int:WDR77 |
| Interaction | TACSTD2 interactions | 4.74e-04 | 129 | 154 | 6 | int:TACSTD2 | |
| Interaction | RPL26L1 interactions | CUL4B RRP1B ESR2 RPS10 SRP9 RUFY1 BLM CUL5 GNL2 TRMT1L COPS5 | 4.90e-04 | 431 | 154 | 11 | int:RPL26L1 |
| Interaction | IGHM interactions | 4.94e-04 | 130 | 154 | 6 | int:IGHM | |
| Interaction | CAND1 interactions | CUL4B DOCK3 HTR2C SFSWAP PUF60 ESR2 POLR2A RPS10 RUFY1 BLM CUL5 BMI1 MRPS21 GNL2 TRMT1L SNRPD1 COPS5 | 4.96e-04 | 894 | 154 | 17 | int:CAND1 |
| Interaction | ILF3 interactions | CUL4B RRP1B LEMD3 POLR2A MBD6 TRIM24 CUL5 BMI1 DAP3 PTCD1 DROSHA MAD1L1 GNL2 EIF3A TRMT1L SNRPD1 COPS5 | 5.08e-04 | 896 | 154 | 17 | int:ILF3 |
| Interaction | PHC3 interactions | 5.17e-04 | 86 | 154 | 5 | int:PHC3 | |
| Interaction | NBN interactions | 5.25e-04 | 183 | 154 | 7 | int:NBN | |
| Interaction | RCBTB1 interactions | 5.26e-04 | 21 | 154 | 3 | int:RCBTB1 | |
| Interaction | LRRC25 interactions | 5.60e-04 | 185 | 154 | 7 | int:LRRC25 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 3.99e-05 | 13 | 96 | 3 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | 3.06e-04 | 242 | 96 | 7 | 403 | |
| GeneFamily | Cullins | 7.65e-04 | 8 | 96 | 2 | 1032 | |
| GeneFamily | COP9 signalosome | 9.80e-04 | 9 | 96 | 2 | 932 | |
| GeneFamily | Sterile alpha motif domain containing | 1.24e-03 | 88 | 96 | 4 | 760 | |
| GeneFamily | Helix-turn-helix CENPB type domain containing | 2.09e-03 | 13 | 96 | 2 | 533 | |
| GeneFamily | Dyneins, axonemal | 3.60e-03 | 17 | 96 | 2 | 536 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP | 3.06e-06 | 198 | 156 | 9 | M3449 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | FNIP2 CUL4B NR2C1 KIF21A POLR2A USP24 RTN3 TRIM24 CLIP1 CUL5 UPF2 MAD1L1 GNL2 TIGD3 PRKAG2 CLSPN | 5.50e-06 | 595 | 151 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | UBR1 NR2C1 KIF21A POLR2A USP24 ARFGEF2 RTN3 NFKBIZ TRIM24 CLIP1 CREB5 UPF2 GNL2 EIF3A PRKAG2 CLSPN | 1.10e-05 | 629 | 151 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CUL4B GCFC2 TTC41P RRP1B IFT74 KIF21A VPS50 ARFGEF2 RFC1 TRIM24 CLIP1 CREB5 PHC1 BLM CUL5 UPF2 CENPH MAD1L1 GNL2 EIF3A FH CLSPN PIBF1 | 2.79e-05 | 1257 | 151 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | ABCA13 FASTKD1 PAQR5 ARFGEF2 JMY GATAD2B CUL5 BLOC1S6 PIBF1 GARRE1 WWC1 | 8.76e-05 | 379 | 151 | 11 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CUL4B DOCK3 GCFC2 TTC41P RRP1B IFT74 KIF21A VPS50 ARFGEF2 RFC1 TRIM24 CLIP1 CREB5 PHC1 BLM CUL5 UPF2 CENPH MAD1L1 GNL2 EIF3A FH CLSPN PIBF1 | 9.89e-05 | 1459 | 151 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.45e-07 | 168 | 156 | 8 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 4.88e-07 | 197 | 156 | 8 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.47e-07 | 200 | 156 | 8 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.32e-06 | 179 | 156 | 7 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.12e-06 | 185 | 156 | 7 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 4.91e-06 | 190 | 156 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.63e-06 | 194 | 156 | 7 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 5.82e-06 | 195 | 156 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 5.82e-06 | 195 | 156 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 6.02e-06 | 196 | 156 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 6.02e-06 | 196 | 156 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.22e-06 | 197 | 156 | 7 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.43e-06 | 198 | 156 | 7 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 6.43e-06 | 198 | 156 | 7 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 6.87e-06 | 200 | 156 | 7 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 6.87e-06 | 200 | 156 | 7 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-05 | 169 | 156 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.92e-05 | 178 | 156 | 6 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.30e-05 | 181 | 156 | 6 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 4.43e-05 | 182 | 156 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.43e-05 | 182 | 156 | 6 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.43e-05 | 182 | 156 | 6 | e6968e0bd9cef92052d04ac54e2dd746b37623f6 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 185 | 156 | 6 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-05 | 187 | 156 | 6 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-05 | 188 | 156 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.31e-05 | 188 | 156 | 6 | 0ec2a1b0505501ba18f10a5fce68c306a6292419 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 5.31e-05 | 188 | 156 | 6 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 5.47e-05 | 189 | 156 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.63e-05 | 190 | 156 | 6 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.80e-05 | 191 | 156 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 5.80e-05 | 191 | 156 | 6 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 5.97e-05 | 192 | 156 | 6 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.14e-05 | 193 | 156 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 6.14e-05 | 193 | 156 | 6 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | Control-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 6.14e-05 | 193 | 156 | 6 | 2a6d531abd34df20941cf3dac4fdfb1621a1bde6 | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 6.32e-05 | 194 | 156 | 6 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-05 | 194 | 156 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.32e-05 | 194 | 156 | 6 | dfe0ece81922bfd7c6673726d3ea2365cbdb5513 | |
| ToppCell | Healthy-Classical_Monocyte|World / disease group, cell group and cell class | 6.50e-05 | 195 | 156 | 6 | 0d96f456cc84ebb2543406fb2374c6d7cedd3c4d | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.50e-05 | 195 | 156 | 6 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class | 6.50e-05 | 195 | 156 | 6 | 0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.50e-05 | 195 | 156 | 6 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.88e-05 | 197 | 156 | 6 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 6.88e-05 | 197 | 156 | 6 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 6.88e-05 | 197 | 156 | 6 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.07e-05 | 198 | 156 | 6 | 82bcd44f8744e7e8477fbfd871a52f3d1a8b3adc | |
| ToppCell | COPD-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 7.27e-05 | 199 | 156 | 6 | 1cf1b2d6debf9e3389f1829dcaa2857e9533a080 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor|LPS_only / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 199 | 156 | 6 | 3a0af1a13b1760f4213d87d0958dbe3bf3b9a42b | |
| ToppCell | critical-Myeloid-Non-resident_Macrophage|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.27e-05 | 199 | 156 | 6 | 193325768b17d3123ae855317f381a01088b5dac | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 199 | 156 | 6 | 0447f8f53389fe7c6ddc04a97d86e74122ea16f4 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|LPS_only / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 199 | 156 | 6 | 7b21447bb39cdba37539a12cb475f463010fc23f | |
| ToppCell | IPF-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 7.27e-05 | 199 | 156 | 6 | 3c2b362d5e824e1a04830e70352f8818de984174 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 199 | 156 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | moderate-Myeloid-Non-resident_Macrophage|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.27e-05 | 199 | 156 | 6 | 614c1e788d89310e78984241977941beed8d12dc | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.48e-05 | 200 | 156 | 6 | c89f3cb36bb14c476d6a392bfd3ded1c8feecfeb | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.48e-05 | 200 | 156 | 6 | e1da1b15d2ca06796ee1ab7cef586ae0b4dc0a0a | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.48e-05 | 200 | 156 | 6 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| Computational | Neighborhood of AATF | 3.04e-05 | 209 | 103 | 10 | MORF_AATF | |
| Disease | Malignant neoplasm of breast | AKAP6 ESR2 ARFGEF2 TRIM29 RUFY1 CLIP1 CUL5 DAP3 FOXP4 ZNF532 MTOR BTK DIP2C TIMELESS PLD2 CLSPN DNAH9 HSPA14 | 1.03e-05 | 1074 | 151 | 18 | C0006142 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.36e-04 | 152 | 151 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | autosomal dominant polycystic kidney disease (is_implicated_in) | 1.55e-04 | 4 | 151 | 2 | DOID:898 (is_implicated_in) | |
| Disease | disease progression measurement | 2.74e-04 | 61 | 151 | 4 | EFO_0008336 | |
| Disease | red blood cell density measurement | STARD13 VIL1 DCDC1 ESR2 ARFGEF2 RFC1 PHC2 MIPOL1 FOCAD BRF1 CEP78 PRKAG2 PIBF1 | 6.17e-04 | 880 | 151 | 13 | EFO_0007978 |
| Disease | retinal detachment, retinal break | 7.62e-04 | 35 | 151 | 3 | EFO_0005773, EFO_0010698 | |
| Disease | testosterone measurement | STARD13 DOCK3 VIL1 UBR1 PDE4A MIA3 MRAS DCDC1 DSCAM ESR2 POLR2A MAU2 NEDD9 FHAD1 THADA UGT2B10 | 8.62e-04 | 1275 | 151 | 16 | EFO_0004908 |
| Disease | Mesothelioma | 1.21e-03 | 41 | 151 | 3 | C0025500 | |
| Disease | ceramide measurement | 1.37e-03 | 235 | 151 | 6 | EFO_0010222 | |
| Disease | nucleus accumbens volume change measurement | 1.39e-03 | 11 | 151 | 2 | EFO_0021493 | |
| Disease | Situs Inversus | 1.39e-03 | 11 | 151 | 2 | C0037221 | |
| Disease | Ashkenazi Jewish disorders | 1.39e-03 | 11 | 151 | 2 | cv:CN118946 | |
| Disease | mean corpuscular hemoglobin concentration | VIL1 ACTRT3 POTEF POLR2A ARFGEF2 MAU2 RFC1 MIPOL1 FOCAD BRF1 UGT2B10 PRKAG2 CLSPN PIBF1 | 1.67e-03 | 1105 | 151 | 14 | EFO_0004528 |
| Disease | schizophrenia, anorexia nervosa | 1.92e-03 | 48 | 151 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | amygdala volume | 1.96e-03 | 13 | 151 | 2 | EFO_0006934 | |
| Disease | extracellular matrix protein 1 measurement | 1.96e-03 | 13 | 151 | 2 | EFO_0008126 | |
| Disease | chronotype measurement | DOCK3 GCFC2 MRAS ESR2 KIF21A STK31 CLIP1 FOXP4 DIP2C PLCB4 TUBD1 MTRF1L | 2.00e-03 | 882 | 151 | 12 | EFO_0008328 |
| Disease | prostate carcinoma | RBM15 ESR2 GATAD2B MIPOL1 NEDD9 DAP3 PHC3 FOXP4 THADA UPF2 MAD1L1 DIP2C | 2.17e-03 | 891 | 151 | 12 | EFO_0001663 |
| Disease | cognitive function measurement, self reported educational attainment | 2.42e-03 | 355 | 151 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | Down syndrome (implicated_via_orthology) | 2.61e-03 | 15 | 151 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 2.61e-03 | 15 | 151 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | Aase Smith syndrome 2 | 2.61e-03 | 15 | 151 | 2 | C2931850 | |
| Disease | Small cell carcinoma of lung | 2.69e-03 | 54 | 151 | 3 | C0149925 | |
| Disease | Seasonal Affective Disorder | 2.98e-03 | 16 | 151 | 2 | C0085159 | |
| Disease | N-acetyl-beta-alanine measurement | 2.98e-03 | 16 | 151 | 2 | EFO_0021430 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 2.98e-03 | 16 | 151 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | sphingomyelin 14:0 measurement | 3.36e-03 | 17 | 151 | 2 | EFO_0010390 | |
| Disease | Colorectal Carcinoma | 3.40e-03 | 702 | 151 | 10 | C0009402 | |
| Disease | Cocaine Abuse | 4.19e-03 | 127 | 151 | 4 | C0009171 | |
| Disease | Coronary Arteriosclerosis | 4.55e-03 | 65 | 151 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 4.55e-03 | 65 | 151 | 3 | C1956346 | |
| Disease | urate measurement, bone density | 4.72e-03 | 619 | 151 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | cortical thickness | AKAP6 FNIP2 CPAMD8 DCDC1 ARFGEF2 SERP2 SERP1 MBD6 RUFY1 GATAD2B THADA PKD1 PRKAG2 | 4.83e-03 | 1113 | 151 | 13 | EFO_0004840 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MKEGLEAARLKAHLM | 231 | Q93088 | |
| KISALALLKMVMHAR | 56 | Q92905 | |
| HKRILKFLQLFMSDM | 401 | Q9UGJ0 | |
| ELRKALNKLASHMVM | 51 | Q9BQE5 | |
| LMAKRMSLILHVQKL | 81 | Q5SNV9 | |
| SQLASKMHSLLALMV | 611 | Q8TC20 | |
| KRNETEKLHLMFSLM | 286 | Q93034 | |
| QLKTIVMATKMAALH | 786 | Q14511 | |
| LTLKSNKNRMDFIHM | 526 | O60477 | |
| AKVMMNLSHEKLVQL | 446 | Q06187 | |
| LMKNHGIMLLSASDR | 191 | Q9BYD9 | |
| LVEMLRAMKQKALSA | 886 | Q14687 | |
| NILVIMAVSMEKKLH | 71 | P28335 | |
| TLLSNFKMHLKMQIE | 461 | Q9Y6D5 | |
| SRALNFTKHLLMMEK | 706 | Q86UQ4 | |
| IITKKDVLRHMAQMA | 736 | P51793 | |
| VRLHDKMKVDMSGLQ | 761 | Q8IYA2 | |
| VFQRRGHDLIMKMKI | 251 | Q8WW22 | |
| IRKNPLIDHSMMKAV | 291 | Q5JTW2 | |
| SVLMKRNLHNVKRMT | 2756 | Q8TDJ6 | |
| LLKNAMRATMESHLD | 276 | O14874 | |
| TMLAVKNITMHLLKK | 421 | Q8N4T0 | |
| LRLLELMNQHDTEMK | 156 | Q9Y463 | |
| MPRKAHSNMLTVKAL | 1671 | Q96BY7 | |
| MILVANKVDLMHLRK | 121 | O14807 | |
| MHLRKITREQGKEMA | 131 | O14807 | |
| MSHRAKLAMSGKIII | 426 | Q96T37 | |
| KMSTERRKLLMEHIF | 466 | P13056 | |
| LLKNMDAHKVMLDLL | 1196 | Q14573 | |
| HMQMEAILLDKTLRK | 266 | Q9NXK6 | |
| LMMNTLYKLHDRLAQ | 526 | Q9Y2U8 | |
| QPMHSEAKMRLKAAL | 226 | Q02930 | |
| AMLRLELDTMKHQSQ | 656 | A5A3E0 | |
| LADLDTMRHKMRQLK | 1571 | M0R2J8 | |
| DMTKLCNHRRKAVAM | 96 | Q96DN6 | |
| MKQSKLPMSLLHDRI | 111 | Q13823 | |
| YVLARKMNALHMLDI | 461 | Q9BYH8 | |
| KMQMELSHKRARVEL | 71 | Q9Y6D9 | |
| MSLTKLADKELVHMI | 296 | Q92731 | |
| MMRAKEICLEQRKHA | 491 | Q8N9B5 | |
| LQTDKMMRAAAKDVH | 1061 | Q8IX03 | |
| IARAKHMEMSLKVLE | 196 | Q8TD10 | |
| LKHINQLLRTMSMPK | 466 | P51654 | |
| TVMHLRKFLRSKMDI | 171 | P35226 | |
| MVAALRKKHADSMAE | 1191 | P13535 | |
| LEAKKLAHAMMEAFR | 206 | Q7Z2X4 | |
| MAQVRALHKIMALFS | 1 | Q8NGF0 | |
| EMASHKFKRMLNREL | 256 | P27815 | |
| SKHMNLLADLKTMVE | 576 | Q08499 | |
| KAMMLRAAVLRNQIH | 451 | Q13098 | |
| VKSRLIKMGHLNSMN | 4241 | Q96JB1 | |
| ELHKINLVVSKGMML | 526 | Q96J66 | |
| LAKVMNLIVFHSRML | 511 | P55160 | |
| MDKLHLNLTELALTM | 676 | P55160 | |
| LAKESERLQAMMAHL | 356 | Q8IVH2 | |
| HDRMLMDKNATALRL | 1066 | P00451 | |
| GHEAMERLKMLALLK | 36 | Q8WXI9 | |
| LLLLKEDHLMSAMNI | 951 | Q8NDX5 | |
| VMMEKELHQLKRASY | 921 | Q6NV74 | |
| AMLRLELDTMKHQSQ | 656 | Q6S8J3 | |
| IPDHARQLTKAMMRK | 246 | P42126 | |
| IKLLLLHGADMMTKN | 296 | Q9GZV1 | |
| HYRQAMLLKAMAALE | 336 | P07199 | |
| IMKLRKDLTEAHSRM | 1011 | B1AJZ9 | |
| MILSTHRNAFKKIME | 506 | Q96LB3 | |
| HDVTRLKRLIMMEKD | 996 | P54132 | |
| LHKKLIDQFQMMRAS | 1611 | Q8IZD9 | |
| ADMADVMRLLSHLKI | 141 | P26232 | |
| RQSSVLMDNMKHLLE | 121 | Q9H3R5 | |
| LMDNMKHLLELNKLI | 126 | Q9H3R5 | |
| MHALLLKQAMTFMKR | 351 | P16383 | |
| EKALEHKNRMSRMLE | 741 | Q14152 | |
| MMIKNVLHSARLLGD | 411 | P07954 | |
| ESHMNRLKSAIEKAM | 341 | Q9P278 | |
| QLLLDKHMGMKRYEV | 1591 | Q8IZJ3 | |
| ADNLKLKTHTMLQLM | 361 | O15063 | |
| HMYLDNMTAKQLKLL | 466 | Q53R41 | |
| QLHKRAEKIAVMLME | 1006 | Q9Y2E4 | |
| DETRAHLLLKEKMMR | 31 | Q9NZK5 | |
| HLEQRLKLMASDMLE | 1036 | Q86UW7 | |
| YHAKLVNIRKEMLML | 111 | Q9UL45 | |
| VNIRKEMLMLHEKTS | 116 | Q9UL45 | |
| SEHLKALINSVMKIM | 466 | Q99698 | |
| LLMKMRSVANDELHV | 2606 | Q99698 | |
| RMLAKQYGHMKIVAL | 206 | Q6ZW76 | |
| VALHSMMKQKERFAA | 276 | Q9Y6V7 | |
| SMERSLLADQKVHML | 821 | Q6PJP8 | |
| QRHLSKLFDNMAKMR | 1626 | Q9NYC9 | |
| LEMARKKMNSEISHR | 796 | A2RUR9 | |
| KKVRLQRLARMHADM | 391 | Q96RP9 | |
| KGMLLLMERKLQEVH | 191 | Q9Y6X3 | |
| RIMKMRKTLSHNLLV | 856 | Q13620 | |
| AAHAKEMEALRAKLM | 686 | P30622 | |
| LIKAIMHLLQMQALK | 101 | Q5VW36 | |
| RSCLKQTLHKLEAMM | 2681 | P98161 | |
| TAMHRAAAKGNLKMI | 141 | O75832 | |
| HLRTSVLLEQMMRKK | 721 | Q9HAU5 | |
| RAMMKLTNSAEVAKH | 256 | Q0VDF9 | |
| QDGLLKMLSLVLMHK | 536 | P42345 | |
| EKTYLRLLAAMNMLH | 871 | Q6ZUA9 | |
| VHMRVKEGSKIRNLM | 36 | Q9BUL9 | |
| KRLRDAKSLAEMLMS | 1626 | O60469 | |
| ELALVHNLRKMMKND | 286 | P51398 | |
| MNAAMVHINRALKLI | 931 | O95197 | |
| HMRKKGINTLINIMS | 936 | Q9NRR4 | |
| LLRLTAIMEKHSMSN | 621 | Q9Y3M8 | |
| DLMAKVRAMLAASKN | 931 | Q12872 | |
| IKVTKMDANVLMHLR | 351 | Q7Z2T5 | |
| MRHVEKMCKADLSRN | 421 | Q14134 | |
| TKIMFKNLLQMHRLT | 411 | Q6YHU6 | |
| TLQRNLHRLKMKMQE | 186 | Q8IYR2 | |
| RKKMRVMSNLVEHNG | 596 | Q14684 | |
| RESKEMRAHQAKISM | 1071 | Q15147 | |
| SARHMVMQKLLRKQE | 446 | Q9UHX1 | |
| SHMHLMAFRKISLKT | 311 | Q1RMZ1 | |
| NLRHKLLELTQKMAM | 1621 | Q5JRA6 | |
| MKKHLMLLSRAADSI | 901 | P35251 | |
| LAMTKLRAKLYSMHL | 286 | Q9UGC7 | |
| LMHMMKLSIKVLLQS | 116 | Q96T51 | |
| KMLGMLFHNIRNILK | 186 | Q5VT98 | |
| MVAKQRIRMANEKHS | 1 | Q8N6R1 | |
| DLALHFLNKMKIMVI | 311 | P50991 | |
| AMLRLELDTMKHQSQ | 656 | P0CG38 | |
| HRMQKEIAALAPSML | 1011 | P0CG38 | |
| ASHKAGLKDMLRMIA | 851 | Q13023 | |
| ILDQMRKMIKHALDF | 191 | P45381 | |
| IHMKTMLDDDKRQLR | 1101 | Q9HAW4 | |
| NLAAKMEILKEMRHV | 366 | Q9BXU1 | |
| PNLHVMKAMQSLKSR | 41 | P46783 | |
| RLLGKTQTAMDQLHM | 261 | Q96JG6 | |
| LKHLRQMLISNAKME | 296 | Q9UJT1 | |
| VKMLHRLAHDLKMEA | 726 | Q9UNS1 | |
| MLLHKAKELADIMGQ | 101 | Q6B0B8 | |
| KLMEVMNHVLGKRRE | 221 | P09327 | |
| TFTKRLMLEKHVQLM | 1096 | Q9HCE3 | |
| LESLAKDHRMKLMQQ | 331 | O15164 | |
| LLLLKEDHLMSAMNI | 826 | Q8IXK0 | |
| LSLLENMSKHTIMLR | 591 | Q8N4P2 | |
| VQDLRHISMGYKMKL | 296 | Q9H2G4 | |
| LAMETRKVMKGNHSR | 681 | Q7Z3J2 | |
| RMKSRHLLDMDEQSK | 146 | Q9H171 | |
| PNLHVMKAMQSLKSR | 41 | Q9NQ39 | |
| MAKHLKFIARTVMVQ | 1 | P82921 | |
| KLMMLQHKIRDTQLE | 681 | Q7Z4S6 | |
| ISIHLASAKERKLMM | 1611 | Q15413 | |
| MVAKQRIRMANEKHS | 1 | Q9Y6X1 | |
| LDRKHMTDRKLTMEQ | 1216 | P24928 | |
| HREELAAMKQILVKM | 681 | Q8WXW3 | |
| TMVRQLMHKLLVFSA | 91 | Q8IV45 | |
| ARLHRQKIMAQMSAL | 1026 | Q8IWV7 | |
| TKLNIFRKHLSIPMM | 501 | Q6P2S7 | |
| MKLVRFLMKLSHETV | 1 | P62314 | |
| ALLLLKEEHLMSAMN | 971 | P78364 | |
| ADSLSLLKKMHRTQM | 766 | P49754 | |
| HEVSMTALRLLQRMK | 201 | Q92994 | |
| IKHLARLMATQMTAA | 446 | Q92797 | |
| LLRMLKSPHFSAKMN | 391 | Q9UPU5 | |
| MNMKTILKELVQRGH | 36 | P36537 | |
| DHLLVLKMIFMNTLR | 306 | Q6ZR37 | |
| KIEKFHSQLMRLMVA | 61 | P49458 | |
| HSQLMRLMVAKEARN | 66 | P49458 | |
| IHERMGKKLTELSMQ | 61 | P62072 | |
| HALLKMAAKCADLRM | 251 | O75127 | |
| SKRALMLLHPNIKVM | 416 | O14939 | |
| SMHRVKDAMLVALKS | 376 | Q5TIE3 |